Mosaic expects the collaboration with the FDA will help address diagnostic capacity constraints in the US healthcare system.
Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing ...
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
Where FDA breakthrough devices stand through 2025: growth, authorizations, leading specialties, AI trends, and qualification pathways explained.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results